ten Kate L P
VU Medisch Centrum, afd. Klinische Genetica en Antropogenetica, Amsterdam.
Ned Tijdschr Geneeskd. 2006 Jul 22;150(29):1608-12.
In the past, prenatal diagnosis of chromosomal abnormalities has been achieved using a microscope to make a visual assessment of the chromosomes in foetal cells which had been obtained by invasive procedures. The results were usually not available until 10-14 days later. Now molecular techniques have become available which provide a result within 24-48 hours. The first generation of these techniques combines speed with a focus on a limited number of frequent and important chromosomal abnormalities. Examples include fluorescence in-situ hybridisation (FISH), quantitative polymerase chain reaction (PCR) and multiple ligation-dependent probe amplification (MLPA). One drawback, therefore, is that other clinically significant chromosomal abnormalities will not be detected. More recently other new techniques have been making their appearance, such as array-comparative genomic hybridisation (CGH), which will allow the detection of clinically significant submicroscopic aberrations.
过去,染色体异常的产前诊断是通过显微镜对经侵入性操作获取的胎儿细胞中的染色体进行视觉评估来实现的。结果通常要在10 - 14天后才能得到。现在有了分子技术,能在24 - 48小时内得出结果。第一代这类技术将速度与专注于有限数量的常见且重要的染色体异常相结合。例子包括荧光原位杂交(FISH)、定量聚合酶链反应(PCR)和多重连接依赖探针扩增(MLPA)。因此,一个缺点是无法检测到其他具有临床意义的染色体异常。最近,其他新技术不断涌现,比如阵列比较基因组杂交(CGH),它能检测出具有临床意义的亚显微畸变。